TY - JOUR
T1 - Surveillance and screening for Barrett's esophagus
T2 - What to do when we have so many patients and so little evidence
AU - Wang, Kenneth K.
PY - 2005/10
Y1 - 2005/10
N2 - Commentary: Screening and surveillance of Barrett's esophagus has been recommended by gastroenterology professional society guidelines in hopes of decreasing the mortality rate from esophageal adenocarcinoma. Although a large number of clinicians believe in the efficacy of both screening and surveillance for Barrett's esophagus, the evidence regarding their value is primarily inferential and based on relatively weak data. Dr. Kenneth Wang examines the current recommendations for screening and surveillance of Barrett's esophagus and reviews the most recent literature assessing their utility. Grace H. Elta, MD. Editor.
AB - Commentary: Screening and surveillance of Barrett's esophagus has been recommended by gastroenterology professional society guidelines in hopes of decreasing the mortality rate from esophageal adenocarcinoma. Although a large number of clinicians believe in the efficacy of both screening and surveillance for Barrett's esophagus, the evidence regarding their value is primarily inferential and based on relatively weak data. Dr. Kenneth Wang examines the current recommendations for screening and surveillance of Barrett's esophagus and reviews the most recent literature assessing their utility. Grace H. Elta, MD. Editor.
UR - http://www.scopus.com/inward/record.url?scp=33745947680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745947680&partnerID=8YFLogxK
U2 - 10.1016/j.clinup.2005.09.001
DO - 10.1016/j.clinup.2005.09.001
M3 - Article
AN - SCOPUS:33745947680
SN - 1070-7212
VL - 13
SP - 1
EP - 4
JO - ASGE Clinical Update
JF - ASGE Clinical Update
IS - 2
ER -